Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Preferred Stock Liabilities: 2018-2019

Historic Preferred Stock Liabilities for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2019 value amounting to $200.6 million.

  • Black Diamond Therapeutics' Preferred Stock Liabilities rose 230.05% to $200.6 million in Q4 2019 from the same period last year, while for Dec 2019 it was $200.6 million, marking a year-over-year increase of 230.05%. This contributed to the annual value of $200.6 million for FY2019, which is 230.05% up from last year.
  • According to the latest figures from FY2019, Black Diamond Therapeutics' Preferred Stock Liabilities is $200.6 million, which was up 230.05% from $60.8 million recorded in FY2018.
  • In the past 5 years, Black Diamond Therapeutics' Preferred Stock Liabilities registered a high of $200.6 million during FY2019, and its lowest value of $60.8 million during FY2018.
  • In the last 2 years, Black Diamond Therapeutics' Preferred Stock Liabilities had a median value of $130.7 million in 2018 and averaged $130.7 million.
  • Data for Black Diamond Therapeutics' Preferred Stock Liabilities shows a peak YoY soared of 230.05% (in 2019) over the last 5 years.
  • Over the past 2 years, Black Diamond Therapeutics' Preferred Stock Liabilities (Yearly) stood at $60.8 million in 2018, then spiked by 230.05% to $200.6 million in 2019.